Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERNETTA
NCT01835236Phase 2Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Mar 2013
- Primary completion
- Jan 2018
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 2 trial of pertuzumab in breast cancer, sponsored by Swiss Group for Clinical Cancer Research. Started Mar 2013; status: completed.
02
Drugs
pertuzumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01835236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01835236.